Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester - PubMed (original) (raw)
Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester
C S Lee et al. J Steroid Biochem Mol Biol. 1996 Jun.
Abstract
In human breast cancer cell lines, an inverse relationship exists between the basal levels of oestrogen receptor (ER) and epidermal growth factor receptor (EGF-R) gene expression. In addition, the tumour-promoting phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) inhibits ER and stimulates EGF-R expression in MCF-7 breast cancer cells. This study aimed to define further the potential mechanisms involved in the modulation of ER and EGF-R gene expression by TPA. ER mRNA levels were reduced after 3 h and declined to 30% of control between 12 and 72 h after exposure to 10 nM TPA. This decrease in mRNA levels was preceded by an apparent fall in ER transcription rate. There was no effect on the stability of ER mRNA following pretreatment for 3-24 h with TPA, supporting the conclusion that the fall in ER mRNA levels was predominantly due to a decrease in ER transcription rate. Levels of EGF-R mRNA increased 10-fold by 12 h due predominantly to an increased transcription rate. The TPA-induced decrease in ER mRNA was unaffected by the simultaneous administration of the protein synthesis inhibitor cycloheximide, whereas the increase in EGF-R mRNA was inhibited by co-incubation with cycloheximide. These data indicate a requirement for continuing protein synthesis for the TPA effect on EGF-R but not on ER mRNA levels. Because the modulation of ER and EGF-R gene expression by TPA is likely to involve the protein kinase C (PKC) signal transduction pathway, the effects of other known activators of PKC were investigated. The non-phorboid tumour promoter mezerein modulated ER (an 80% decrease) and EGF-R (a 20-fold increase) mRNA levels in a similar manner to TPA. In contrast, neither 1,2-dioctanoyl-sn-glycerol (DiC8) nor 1-oleoyl-2-acetyl-sn-glycerol (OAG), both permeant analogues of the endogenous physiological activators of PKC, affected ER and EGF-R mRNA levels. These latter results were not due to a lack of efficacy because a single administration of DiC8 was as effective as TPA in inducing c-fos mRNA at 30 min. However DiC8 was less active in the later induction of c-myc mRNA. These data demonstrate reciprocal regulation of ER and EGF-R gene expression by TPA, involving effects on transcriptional events, which appear to be mediated by sustained activation of PKC.
Similar articles
- Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells.
Ormandy CJ, Lee CS, Kelly PA, Sutherland RL. Ormandy CJ, et al. J Cell Biochem. 1993 May;52(1):47-56. doi: 10.1002/jcb.240520108. J Cell Biochem. 1993. PMID: 8320275 - Modulation of estrogen receptor and epidermal growth factor receptor mRNAs by phorbol ester in MCF 7 breast cancer cells.
Lee CS, Koga M, Sutherland RL. Lee CS, et al. Biochem Biophys Res Commun. 1989 Jul 14;162(1):415-21. doi: 10.1016/0006-291x(89)92013-5. Biochem Biophys Res Commun. 1989. PMID: 2751660 - Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
Richards JA, Petrel TA, Brueggemeier RW. Richards JA, et al. J Steroid Biochem Mol Biol. 2002 Feb;80(2):203-12. doi: 10.1016/s0960-0760(01)00187-x. J Steroid Biochem Mol Biol. 2002. PMID: 11897504 Review. - EGF receptor expression, regulation, and function in breast cancer.
Chrysogelos SA, Dickson RB. Chrysogelos SA, et al. Breast Cancer Res Treat. 1994 Jan;29(1):29-40. doi: 10.1007/BF00666179. Breast Cancer Res Treat. 1994. PMID: 8018962 Review.
Cited by
- Molecular and cellular determinants of estrogen receptor alpha expression.
Pinzone JJ, Stevenson H, Strobl JS, Berg PE. Pinzone JJ, et al. Mol Cell Biol. 2004 Jun;24(11):4605-12. doi: 10.1128/MCB.24.11.4605-4612.2004. Mol Cell Biol. 2004. PMID: 15143157 Free PMC article. Review. No abstract available. - Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
Biswas DK, Cruz AP, Gansberger E, Pardee AB. Biswas DK, et al. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8542-7. doi: 10.1073/pnas.97.15.8542. Proc Natl Acad Sci U S A. 2000. PMID: 10900013 Free PMC article. - Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells.
Yi YW, You KS, Han S, Ha IJ, Park JS, Lee SG, Seong YS. Yi YW, et al. Cancers (Basel). 2022 Oct 24;14(21):5215. doi: 10.3390/cancers14215215. Cancers (Basel). 2022. PMID: 36358633 Free PMC article. - Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.
Morelli C, Lanzino M, Garofalo C, Maris P, Brunelli E, Casaburi I, Catalano S, Bruno R, Sisci D, Andò S. Morelli C, et al. Mol Cell Biol. 2010 Feb;30(3):857-70. doi: 10.1128/MCB.00824-09. Epub 2009 Nov 23. Mol Cell Biol. 2010. PMID: 19933843 Free PMC article. - Phospholipase C delta-4 overexpression upregulates ErbB1/2 expression, Erk signaling pathway, and proliferation in MCF-7 cells.
Leung DW, Tompkins C, Brewer J, Ball A, Coon M, Morris V, Waggoner D, Singer JW. Leung DW, et al. Mol Cancer. 2004 May 13;3:15. doi: 10.1186/1476-4598-3-15. Mol Cancer. 2004. PMID: 15140260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous